Compounds of Formula I ##STR1## are disclosed as inhibitors having activity against the aspartyl proteases, plasmepsin and cathepsin D. The compounds are therefore useful for treatment of {HEAD ~ diseases} such as malaria and {TAIL ~ Alzheimers disease} 
Compounds of Formula I # # STR1 # # are disclosed as inhibitors having activity against the aspartyl proteases , plasmepsin and cathepsin D. The compounds are therefore useful for treatment of { HEAD ~ diseases } such as malaria and { TAIL ~ Alzheimers disease }
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD REL REL OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL